1. Home
  2. VIR vs WLDN Comparison

VIR vs WLDN Comparison

Compare VIR & WLDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VIR
  • WLDN
  • Stock Information
  • Founded
  • VIR 2016
  • WLDN 1964
  • Country
  • VIR United States
  • WLDN United States
  • Employees
  • VIR N/A
  • WLDN N/A
  • Industry
  • VIR Biotechnology: Pharmaceutical Preparations
  • WLDN Military/Government/Technical
  • Sector
  • VIR Health Care
  • WLDN Consumer Discretionary
  • Exchange
  • VIR Nasdaq
  • WLDN Nasdaq
  • Market Cap
  • VIR 706.4M
  • WLDN 826.2M
  • IPO Year
  • VIR 2019
  • WLDN 2006
  • Fundamental
  • Price
  • VIR $4.38
  • WLDN $106.27
  • Analyst Decision
  • VIR Strong Buy
  • WLDN Strong Buy
  • Analyst Count
  • VIR 8
  • WLDN 3
  • Target Price
  • VIR $30.25
  • WLDN $91.33
  • AVG Volume (30 Days)
  • VIR 1.0M
  • WLDN 527.9K
  • Earning Date
  • VIR 08-06-2025
  • WLDN 08-07-2025
  • Dividend Yield
  • VIR N/A
  • WLDN N/A
  • EPS Growth
  • VIR N/A
  • WLDN 94.22
  • EPS
  • VIR N/A
  • WLDN 2.39
  • Revenue
  • VIR $19,000,000.00
  • WLDN $628,172,000.00
  • Revenue This Year
  • VIR N/A
  • WLDN N/A
  • Revenue Next Year
  • VIR $0.56
  • WLDN $9.94
  • P/E Ratio
  • VIR N/A
  • WLDN $44.31
  • Revenue Growth
  • VIR N/A
  • WLDN 13.82
  • 52 Week Low
  • VIR $4.16
  • WLDN $30.43
  • 52 Week High
  • VIR $14.45
  • WLDN $121.00
  • Technical
  • Relative Strength Index (RSI)
  • VIR 35.16
  • WLDN 62.34
  • Support Level
  • VIR $4.33
  • WLDN $85.74
  • Resistance Level
  • VIR $4.57
  • WLDN $121.00
  • Average True Range (ATR)
  • VIR 0.22
  • WLDN 6.76
  • MACD
  • VIR -0.02
  • WLDN -0.80
  • Stochastic Oscillator
  • VIR 21.53
  • WLDN 59.86

About VIR Vir Biotechnology Inc.

Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.

About WLDN Willdan Group Inc.

Willdan Group Inc is a provider of professional technical and consulting services to utilities, private industry, and public agencies at all levels of government. It operates in the business segments of Energy and Engineering and Consulting. It generates the majority of its revenue from the Energy segment, which includes services such as audit and surveys, program design, master planning, benchmarking analysis, design engineering, construction management, performance contracting, installation, advances in software and data analytics, and other services. All of its revenue is derived from the domestic markets.

Share on Social Networks: